Moreover, PTX3, by recruiting Factor H or inhibiting angiogenesis, can also lead to a reduced inflammatory response, carcinogenesis and angiogenesis in other tumor contexts37,38 and in this scenario the binding to C1q could reduce complement activation5. This evidence concerns the gene PTX3 and neoplasm.